Research Summary
The human microbiome refers to the diverse and complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body, such as the skin, mouth, gut, and other mucosal surfaces. This microbial ecosystem plays a crucial role in maintaining health by contributing to digestion, nutrient absorption, immune system development, and protection against harmful pathogens. The composition of the human microbiome is highly individualized, influenced by factors such as genetics, diet, environment, and lifestyle. Imbalances in the microbiome, known as dysbiosis, have been linked to various health conditions, including autoimmune diseases, gastrointestinal disorders, and metabolic disorders. Ongoing research in microbiome science is uncovering the intricate relationships between the microbiome and human health, with potential implications for personalized medicine and therapeutic interventions.
According to DIResearch's in-depth investigation and research, the global Human Microbiome market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Human Microbiome include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Ritter Pharmaceuticals, Metabiomics, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Human Microbiome. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Microbiome market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Microbiome Include:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Ritter Pharmaceuticals
Metabiomics
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Human Microbiome Product Segment Include:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Human Microbiome Product Application Include:
Treatment
Diagnosis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Human Microbiome Industry PESTEL Analysis
Chapter 3: Global Human Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Human Microbiome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Human Microbiome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Human Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Human Microbiome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Human Microbiome Market Overview 1.1 Product Definition and Statistical Scope 1.2 Human Microbiome Product by Type 1.2.1 Global Human Microbiome Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Gastrointestinal Tract Human Micobiome 1.2.3 Urogenital Tract Human Micobiome 1.2.4 Others 1.3 Human Microbiome Product by Application 1.3.1 Global Human Microbiome Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Treatment 1.3.3 Diagnosis 1.4 Global Human Microbiome Market Revenue Analysis (2019-2030) 1.5 Human Microbiome Market Development Status and Trends 1.5.1 Human Microbiome Industry Development Status Analysis 1.5.2 Human Microbiome Industry Development Trends Analysis 2 Human Microbiome Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Human Microbiome Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Human Microbiome Market Analysis by Regions 4.1 Human Microbiome Overall Market: 2023 VS 2024 VS 2030 4.2 Global Human Microbiome Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Human Microbiome Revenue and Market Share by Region (2019-2024) 4.2.2 Global Human Microbiome Revenue Forecast by Region (2025-2030) 5 Global Human Microbiome Market Size by Type and Application 5.1 Global Human Microbiome Market Size by Type 5.2 Global Human Microbiome Market Size by Application 6 North America 6.1 North America Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Human Microbiome Market Size by Type 6.4 North America Human Microbiome Market Size by Application 6.5 North America Human Microbiome Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Human Microbiome Market Size by Type 7.4 Europe Human Microbiome Market Size by Application 7.5 Europe Human Microbiome Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Human Microbiome Market Size by Type 8.4 China Human Microbiome Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Human Microbiome Market Size by Type 9.4 APAC (excl. China) Human Microbiome Market Size by Application 9.5 APAC (excl. China) Human Microbiome Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Human Microbiome Market Size by Type 10.4 Latin America Human Microbiome Market Size by Application 10.5 Latin America Human Microbiome Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Human Microbiome Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Human Microbiome Market Size by Type 11.4 Middle East & Africa Human Microbiome Market Size by Application 11.5 Middle East & Africa Human Microbiome Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Human Microbiome Market Revenue by Key Manufacturers (2020-2024) 12.2 Human Microbiome Competitive Landscape Analysis and Market Dynamic 12.2.1 Human Microbiome Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Vedanta 13.1.1 Vedanta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Vedanta Human Microbiome Product Portfolio 13.1.3 Vedanta Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Seres Therapeutics 13.2.1 Seres Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Seres Therapeutics Human Microbiome Product Portfolio 13.2.3 Seres Therapeutics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Second Genome 13.3.1 Second Genome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Second Genome Human Microbiome Product Portfolio 13.3.3 Second Genome Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Rebiotix 13.4.1 Rebiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Rebiotix Human Microbiome Product Portfolio 13.4.3 Rebiotix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 ActoGeniX 13.5.1 ActoGeniX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 ActoGeniX Human Microbiome Product Portfolio 13.5.3 ActoGeniX Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Enterome BioScience 13.6.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Enterome BioScience Human Microbiome Product Portfolio 13.6.3 Enterome BioScience Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 AvidBiotics 13.7.1 AvidBiotics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 AvidBiotics Human Microbiome Product Portfolio 13.7.3 AvidBiotics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 4D Pharma Research Ltd 13.8.1 4D Pharma Research Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 4D Pharma Research Ltd Human Microbiome Product Portfolio 13.8.3 4D Pharma Research Ltd Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Enterologics 13.9.1 Enterologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Enterologics Human Microbiome Product Portfolio 13.9.3 Enterologics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Metabogen 13.10.1 Metabogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Metabogen Human Microbiome Product Portfolio 13.10.3 Metabogen Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Ritter Pharmaceuticals 13.11.1 Ritter Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Ritter Pharmaceuticals Human Microbiome Product Portfolio 13.11.3 Ritter Pharmaceuticals Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Metabiomics 13.12.1 Metabiomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Metabiomics Human Microbiome Product Portfolio 13.12.3 Metabiomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Osel 13.13.1 Osel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Osel Human Microbiome Product Portfolio 13.13.3 Osel Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Symberix 13.14.1 Symberix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Symberix Human Microbiome Product Portfolio 13.14.3 Symberix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Miomics 13.15.1 Miomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Miomics Human Microbiome Product Portfolio 13.15.3 Miomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Symbiotix Biotherapies 13.16.1 Symbiotix Biotherapies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Symbiotix Biotherapies Human Microbiome Product Portfolio 13.16.3 Symbiotix Biotherapies Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.17 MicroBiome Therapeutics LLC 13.17.1 MicroBiome Therapeutics LLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Portfolio 13.17.3 MicroBiome Therapeutics LLC Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Human Microbiome Industry Chain Analysis 14.2 Human Microbiome Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Human Microbiome Typical Downstream Customers 14.4 Human Microbiome Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support